Mabylon
Mabylon is a developer of human-derived antibodies for allergy treatment founded in 2015.
Also Known As
Mabylon AG
Company Operating Status
Active
Country
Crunchbase URL
Email Address
info@mabylon.com
Founded Date
2015
Headquarters
Latest Funding Round Date
August 12, 2025
Latest Funding Round Amount (USD)
37,000,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
37,000,000
Official Website
Find more companies like Mabylon
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.